Today I wanted to discuss precision medicine and its application in bioinformatics. My name is Rutvi Vaja and I am currently working with Pine Biotech, a Bioinformatics company dedicated to work on bioinformatics education and research as a campus ambassador. Together we started a student club called “SCIOMICS”. The goal of the SCIOMICS Club is to help students learn about bioinformatics research via group sessions, easy to take courses, debates and discussions. Bioinformatics and its related domains are vast and offer a great opportunity for students of life sciences to forge their own path. This club welcomes students from all fields of life sciences to come meet together and learn from and with each other. The SCIOMICS club aims at encouraging young minds to push their critical thinking limits beyond the school and college curriculum.
Tailoring medications for the personal treatment of a patient of one kind of patient has left us all amazed. This takes us back to the Generation where we talk about Personalized Medicine. Personalized medicine is also known as precision medicine is the tailoring of medical treatment to the individual characteristics of each patient. Equipped with tools that are more precise, this technology has enabled physicians to select a therapy or treatment protocol based on a patient’s molecular profile that may not only minimize harmful side effects and ensure a more successful outcome but can also help contain costs compared with a “trial-and-error” approach to disease treatment.
Personalized medicine has the potential to change the way we think about, identify and manage health problems. It is already having an exciting impact on both clinical research and patient care, and this impact will grow as our understanding and technologies improve. Now, who would not love to live in a “Health-Secure” Nation?
Personalized medicine is a multifaceted approach. Precision medicine has set the mark so high for us that using those technologies Melanoma and Breast cancer may be Curable. With such technologies when we get a higher hand on treating genetic and hereditary Disorders.
I have also recorded a short video about personalized medicine and NGS future.
The personalized medicine approach allows physicians to profile genetic variation and other non-obvious patient characteristics as a basis for understanding disease drivers in each patient, in order to select the medicine or treatment that will increase the likelihood of a successful outcome with a more favorable safety profile.
“Precision medicine” approaches – involving the use of tests to guide dose selection, or to help predict which patients are likely to respond to drug treatment or have a high risk for adverse events – has allowed products that treat cardiovascular disease, HIV/AIDS, cancer, multiple sclerosis, and other diseases to be marketed and used more safely. In a growing number of cases, a test is developed together with medicine in order to support the safe and effective use of the medicine. Such a test is called a companion diagnostic because it provides essential information for determining whether a patient is eligible to receive the associated therapy.
Personalized medicine allows preventive or therapeutic interventions to be focused on those most likely to benefit, sparing expense and side effects for those who are not. To advance the practice of personalized medicine, Pfizer has adopted a “precision medicine” paradigm for biopharmaceutical R&D, to help enable the development of therapies capable of delivering more meaningful benefits based on a deeper understanding of disease mechanisms and the ability to target therapies to defined patient populations.
The brave new world enabled by genomic science will undoubtedly change the longer term of drugs. Chronic diseases, however, are caused by multiple, interrelated complex pathways and environmental influences, resulting in an inherent limitation within the role of a gene-centered approach to individualizing prevention.
Genomic interventions that take into consideration environmental interactions are going to be needed to unlock the complete potential of genomic medicine for chronic disease prevention. Integration of personalized medicine with population-based interventions and studies may overcome a number of the present limitations of personalized medicine and ultimately cause the foremost widespread translational preventive benefits from genomics.
Thank you for reading this article and I hope that this resource is being helpful to you. Sciomics aims to encourage young minds to push their critical thinking limits beyond the school and college curriculum and to promote inquisitiveness and inculcate principles of applied learning among the students. The focus of the club is to debate and discuss ideas and build up the spirit of scientific enquiry among the members.
Email us if you are interested in joining the SCIOMICS Club or interact with us via the Group link. We will follow up with your request as soon as possible from our end.
WhatsApp group link:
All ages welcome!
Please check out our upcoming Omicslogic program on Precision Cancer research, Bioinformatics for Precision oncology :
This 1 month training program has been designed to help you explore how the various -omics data types from these sources can be analyzed to understand the basic biology associated with cancer onset, development, and outcomes. We will also learn from examples that demonstrate how large-scale clinical trials and biomedical studies provide an opportunity to improve diagnosis of patients and precision treatment of cancer.